Dr. Paciucci is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
900 Sw 16th St., Suite 100
Renton, WA 98057Phone+1 425-204-7480Fax+1 425-204-7481
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1980 - 1983
- Sapienza University of RomeClass of 1973
- Liceo Scientifico �Augusto Righi�Bachelor, 1962 - 1967
Certifications & Licensure
- NY State Medical License 1983 - 2024
- PA State Medical License 2016 - 2021
- ND State Medical License 2016 - 2018
- WA State Medical License 2013 - 2018
- ID State Medical License 2013 - 2017
- WI State Medical License 2013 - 2017
Publications & Presentations
PubMed
- 155 citationsPostremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-d...Richard Stone, Deborah T. Berg, Stephen L. George, Richard K. Dodge, PA Paciucci
Blood. 2001-08-01 - 326 citationsGranulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous LeukemiaRichard Stone, Deborah T. Berg, Stephen L. George, Richard K. Dodge, PA Paciucci
The New England Journal of Medicine. 1995-06-22 - 92 citationsSurgical treatment of spinal cord compression from epidural metastasis.Narayan Sundaresan, Ved Prakash Sachdev, James F. Holland, Frank Moore, Max Sung
Journal of Clinical Oncology. 1995-09-01
Journal Articles
- Neoadjuvant therapy with dose-dense docetaxel plus short-term filgrastim rescue for locally advanced breast cancerP.A. Paciucci, Raptis, G., Bleiweiss, I., Weltz, C., Lehrer, D., Gurry, R., Anti-cancer Drugs, 1/1/2002
- Post Remission Therapy in Older Patients with de novo Acute Myeloid Leukemia (AML): A Randomized Trial of Mitoxantrone/Intermediate Dose Cytarabine (CALGB Study 8923)Stone, R., Berg, D.T., George, S.l., Dodge, R.K. Paciucci, P.A., Schulman, P., Lee, E.J., Moore, J.O., Powell, B., Bloomfield, C., Schiffer, C.A., Blood, 1/1/2001
- Interleukin-2 plus chemotherapy for patients with metastatic melanomaPaciucci, P.A., Mauri, S., Ryder, S.J., Mandeli, J., Morris, J.C., Holland, J.F., Melanoma Research, 1/1/2000
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Dose-dense Neoadjuvant Taxotere for stage III breast Cancer.Paciucci, P.A., ASCO, 1/1/2002
- A Phase I-II of Topotecan and Cladribinr with Granulocyte Stimulating Factor (G-CFS) Support in Relapsed, Refractory and Poor Prognosis Acute Myeloid Leukemia.L.R. Silverman, R. Jakubowski, P.A. Paciucci, R. Brenner, E. Scigliano, J. Gabrilove, Am Soc Hemat, 1/1/2001
- Meningiona cell lines derived from human tumor explants: establishment, characterization and proliferation analysis.Paino, J.E., Hague, K., Ryder, J.S., Paciucci, P.A., Sen, C., Proc Am Assoc Neurological Surgeons, 1/1/1998
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: